Aurobindo Pharma reported INR12.91B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Cipla INR 7.49B 4.2B Mar/2026
Divis Laboratories Ltd INR 9.63B 1.09B Mar/2026
Dr.Reddys Laboratories INR 4.58B 11.09B Mar/2026
Hindustan Unilever INR 36.77B 1.81B Mar/2026
Sun Pharmaceuticals INR 42.27B 595.5M Dec/2025
UPL INR 7.27B 850M Dec/2025